TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors (NASDAQ:TGTX)

seekingalpha.com · 2026-08-22

TG Therapeutics is a prime takeover target, fueled by Briumvi's growth and recent subcutaneous formulation de-risking. Learn why TGTX stock is a buy.